R&D spending and CRO market size in the U.S. pharma industry 2012-2015
This graph shows the projected growth of R&D spending and the CRO (contract research organization) market size within the pharmaceutical industry in the United States. R&D spending among top 500 pharma companies amounted to over 133 billion U.S. dollars in 2012; this number is expected to surpass the 140 billion mark by the end of 2015.